News Agency
The Times

Fapon Biopharma's Anti-CD47 Antibody FP002 Earns IND Approval from FDA

  • Written by PR Newswire

SHENZHEN, China, Feb. 22, 2023 /PRNewswire/ -- Fapon Biopharma, an innovative biotech company, announced today that its Investigational New Drug (IND) application of FP002, an anti-CD47 monoclonal antibody drug candidate, has been approved by FDA for clinical trials.

FP002 is a humanized anti-CD47 IgG4 monoclonal antibody, developed and...

Read more: Fapon Biopharma's Anti-CD47 Antibody FP002 Earns IND Approval from FDA

How Does Temporary Fencing Help Simplify Project Planning?

Why Does Temporary Fencing Matter During Project Planning?  A controlled boundary is essential when construction, infrastructure maintenance, demolition,  landscaping, and other projects are underway. That is when temporary fencing becomes an important  option to consider. The fencing layout affects more than site... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion